Yearly Archives: 2020

This is a collection of some online resources that have been developed to help us understand and learn more about anti-Black racism, White privilege and our long history of systemic racism.  We trust that these resources will play an important role in equipping our members both individually and collectively to make meaningful and impactful changes […]

CAREB-ACCER has received many questions about how REBs and their institutions are, and should be, managing in-person research since the beginning of the pandemic. We are conducting this survey to collect information on this topic in the hope that it can provide helpful guidance to REBs, institutions and other organizations, such as the Secretariat on […]

BACKGROUND On May 27, 2020 Health Canada, the Canadian Institutes of Health Research (CIHR) and the Canadian Association of Research Ethics Boards (CAREB-ACCER) published a “Joint Statement on Clinical Trial Oversight in Canada” in response to the COVID-19 pandemic and the need to prioritize both Health Canada and REB review of COVID-19 clinical trials.  In […]

Statement from CAREB-ACCER’s Board of Directors on Anti-Black Racism August 18, 2020 To the CAREB-ACCER and broader Research Ethics Community, In light of the protests taking place over the past few months across the U.S., Canada and the world, we want to make it clear that CAREB-ACCER’s Board of Directors denounces anti-Black racism and all […]

On June 30, 2020, the research ethics community lost Dr. Ronald J. Heslegrave (Ron), a great leader and mentor in the field who left behind a legacy of positive academic and professional achievements.  Ron received his PhD in Psychology from the University of Toronto and was an Associate Professor in the Departments of Psychiatry, Public […]

Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB-ACCER), issued a Joint Statement on Clinical Trials Oversight in Canada recognizing the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical […]

AREB-ACCERlaunchesCOVID-19 Forum CAREB-ACCER has created a new Open Forum dedicated to COVID-19 to help the research ethics community discuss issues and share information. This Forum is open to any person with a CAREB-ACCER account, whether or not they have an active membership. Three Topics are live:Clinical TrialsREB Guidance for researchers in the wake of COVID19REB […]

CAREB-ACCER 2020 Conference Update Given the quickly escalating situation with COVID-19, including the fact that many Canadian institutions are not allowing travel, the CAREB-ACCER conference will not take place on April 1 – 3, 2020. We will begin issuing refunds as of March 18, 2020. Please note that this may take a few days. We […]

A draft guidance text is available below for REBs who wish to issue a statement regarding research conduct and review given the COVID-19 situation. French translation to follow shortly. We will list other guidance as it becomes available. (Updated Oct. 7, 2020) Hastings Centre: https://www.thehastingscenter.org/ University of Guelph: https://www.uoguelph.ca/research/article/2019-novel-coronavirus-information Trillium Health Partners:  http://trilliumhealthpartners.ca/researchandinnovation/Pages/Research-Ethics-Board.aspx UBC: https://research.ubc.ca/covid-19-curtailing-research-activities-ubc-campuses University of Ottawa: https://research.uottawa.ca/ethics/guidelines-covid-19 University […]